← Evidence map

ArticleFrontiers in oncology2026

Beyond dual targeting: redefining the treatment horizon for true extramedullary myeloma? - a critical appraisal.

Qinghua Ke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 42063705